Calcineurin is an important factor involved in glucose uptake in human adipocytes

Molecular and Cellular Biochemistry

Volumn 445, Issue 1-2, 2018, Pages 157-168

  Fonseca, Ana Catarina R G ^a,b   Carvalho, Eugénia ^b,c,d,e   Eriksson, Jan W ^a   Pereira, Maria J ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c The Portuguese Diabetes Association (APDP)   (Portugal)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e ARKANSAS CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Adipocytes; Adipose tissue; Calcineurin inhibitors; Diabetes; Gene expression; Glucose uptake

Indexed keywords

ACTIN DEPOLYMERIZING FACTOR; BETA GLUCURONIDASE; CALCINEURIN; CLATHRIN HEAVY CHAIN; CYCLOHEXIMIDE; CYCLOSPORINE; DACTINOMYCIN; DELTAMETHRIN; EZRIN; FK 506 BINDING PROTEIN; GELSOLIN; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; LIM KINASE 1; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MOESIN; MYOSIN LIGHT CHAIN; NCK PROTEIN; OKADAIC ACID; PHOSPHATIDATE PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROFILIN; PROTEIN P21; RADIXIN; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; SYNTAXIN 4; TACROLIMUS; CALCINEURIN INHIBITOR; INSULIN; NITRILE; PHOSPHOPROTEIN PHOSPHATASE; PYRETHROID; SLC2A4 PROTEIN, HUMAN;

ADIPOCYTE; ADULT; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNALIZATION; LONG TERM CARE; MALE; MIDDLE AGED; RADIOACTIVITY; SUBCUTANEOUS FAT; AGED; ANTAGONISTS AND INHIBITORS; CELL MEMBRANE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION PROFILING; METABOLISM; PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADULT; AGED; CALCINEURIN; CALCINEURIN INHIBITORS; CELL MEMBRANE; CYCLOSPORINE; ENDOCYTOSIS; FEMALE; GENE EXPRESSION PROFILING; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; MALE; MIDDLE AGED; NITRILES; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PYRETHRINS; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; TACROLIMUS; TRANSCRIPTION, GENETIC;

EID: 85041096322     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-017-3261-0     Document Type: Article

References (52)

1. IDF (2015) International diabetes federation diabetes Atlas Sixth Edition (Internet). http://www.idf.org/diabetesatlas/update-2014
2. Brown A, Reynolds LR, Bruemmer D (2010) Intensive glycemic control and cardiovascular disease: an update. Nat Rev Cardiol 7:369–375
3. Aramburu J, Heitman J, Crabtree GR (2004) Calcineurin: a central controller of signalling in eukaryotes. EMBO Rep 5:343–348
4. Parekh J, Corley DA, Feng S (2012) Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation. Am J Transplant 12:2181–2187
5. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC (2002) Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 25:583–592
6. Chakkera HA, Kudva Y, Kaplan B (2016) Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus. Clin Pharmacol Ther 101:114–120
7. van Hooff JP, Christiaans MH, van Duijnhoven EM (2004) Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant 19(Suppl 6):vi8–vi12
8. Lopes P, Fuhrmann A, Sereno J, Pereira MJ, Nunes P, Pedro J, Melao A, Reis F, Carvalho E (2013) Effects of cyclosporine and sirolimus on insulin-stimulated glucose transport and glucose tolerance in a rat model. Transplant Proc 45:1142–1148
9. Kwon S, Hermayer KL (2013) Glucocorticoid-induced hyperglycemia. Am J Med Sci 345:274–277
10. Pereira MJ, Palming J, Rizell M, Aureliano M, Carvalho E, Svensson MK, Eriksson JW (2014) Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell-surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents. J Clin Endocrinol Metab 99:e1885–e1894
11. Lopes PC, Fuhrmann A, Sereno J, Espinoza DO, Pereira MJ, Eriksson JW, Reis F, Carvalho E (2014) Short and long term in vivo effects of Cyclosporine A and Sirolimus on genes and proteins involved in lipid metabolism in Wistar rats. Metabolism 63:702–715
12. Pereira MJ, Palming J, Rizell M, Aureliano M, Carvalho E, Svensson MK, Eriksson JW (2013) The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue. Mol Cell Endocrinol 365:260–269
13. Leto D, Saltiel AR (2012) Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 13:383–396
14. Kioumourtzoglou D, Sadler JB, Black HL, Berends R, Wellburn C, Bryant NJ, Gould GW (2014) Studies of the regulated assembly of SNARE complexes in adipocytes. Biochem Soc Trans 42:1396–1400
15. Silverman-Gavrila LB, Charlton MP (2009) Calcineurin and cytoskeleton in low-frequency depression. J Neurochem 109:716–732
16. Goto S, Yamamoto H, Fukunaga K, Iwasa T, Matsukado Y, Miyamoto E (1985) Dephosphorylation of microtubule-associated protein 2, tau factor, and tubulin by calcineurin. J Neurochem 45:276–283
17. Gratuze M, Noel A, Julien C, Cisbani G, Milot-Rousseau P, Morin F, Dickler M, Goupil C, Bezeau F, Poitras I, Bissonnette S, Whittington RA, Hebert SS, Cicchetti F, Parker JA, Samadi P, Planel E (2015) Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington’s disease. Hum Mol Genet 24:86–99
18. Garver TD, Lehman RA, Billingsley ML (1996) Microtubule assembly competence analysis of freshly-biopsied human tau, dephosphorylated tau, and Alzheimer tau. J Neurosci Res 44:12–20
19. Gong CX, Wegiel J, Lidsky T, Zuck L, Avila J, Wisniewski HM, Grundke-Iqbal I, Iqbal K (2000) Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain. Brain Res 853:299–309
20. Taniguchi T, Kawamata T, Mukai H, Hasegawa H, Isagawa T, Yasuda M, Hashimoto T, Terashima A, Nakai M, Mori H, Ono Y, Tanaka C (2001) Phosphorylation of tau is regulated by PKN. J Biol Chem 276:10025–10031
21. Cousin MA, Robinson PJ (2001) The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis. Trends Neurosci 24:659–665
22. Wu XS, Zhang Z, Zhao WD, Wang D, Luo F, Wu LG (2014) Calcineurin is universally involved in vesicle endocytosis at neuronal and nonneuronal secretory cells. Cell Rep 7:982–988
23. Sun T, Wu XS, Xu J, McNeil BD, Pang ZP, Yang W, Bai L, Qadri S, Molkentin JD, Yue DT, Wu LG (2010) The role of calcium/calmodulin-activated calcineurin in rapid and slow endocytosis at central synapses. J Neurosci 30:11838–11847
24. Ryder JW, Bassel-Duby R, Olson EN, Zierath JR (2003) Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways. J Biol Chem 278:44298–44304
25. Ryder JW, Long YC, Nilsson E, Mahlapuu M, Zierath JR (2005) Effects of calcineurin activation on insulin-, AICAR- and contraction-induced glucose transport in skeletal muscle. J Physiol 567:379–386
26. Wang CH, Chen YF, Wu CY, Wu PC, Huang YL, Kao CH, Lin CH, Kao LS, Tsai TF, Wei YH (2014) Cisd2 modulates the differentiation and functioning of adipocytes by regulating intracellular Ca2+ homeostasis. Hum Mol Genet 23:4770–4785
27. Draznin B (1988) Intracellular calcium, insulin secretion, and action. Am J Med 85:44–58
28. Draznin B (1993) Cytosolic calcium and insulin resistance. Am J Kidney Dis 21:32–38
29. Lukaski HC, Bolonchuk WW, Hall CB, Siders WA (1986) Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 60:1327–1332
30. Bialojan C, Takai A (1988) Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J 256:283–290
31. Cohen P, Holmes CF, Tsukitani Y (1990) Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem Sci 15:98–102
32. Enan E, Matsumura F (1992) Specific inhibition of calcineurin by type II synthetic pyrethroid insecticides. Biochem Pharmacol 43:1777–1784
33. Makoveichuk E, Vorrsjo E, Olivecrona T, Olivecrona G (2017) TNF-alpha decreases lipoprotein lipase activity in 3T3-L1 adipocytes by up-regulation of angiopoietin-like protein 4. Biochim Biophys Acta 1862:533–540
34. Calvo RM, Obregon MJ (2009) Tri-iodothyronine upregulates adiponutrin mRNA expression in rat and human adipocytes. Mol Cell Endocrinol 311:39–46
35. Marton MJ, DeRisi JL, Bennett HA, Iyer VR, Meyer MR, Roberts CJ, Roland Stoughton JB, Slade D, Dai H Jr, Hartwell LH, Brown PO, Friend SH (1998) Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med 4:1293–1301
36. Lundgren M, Svensson M, Lindmark S, Renstrom F, Ruge T, Eriksson JW (2007) Fat cell enlargement is an independent marker of insulin resistance and ‘hyperleptinaemia’. Diabetologia 50:625–633
37. Yu ZW, Jansson PA, Posner BI, Smith U, Eriksson JW (1997) Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation. Diabetologia 40:1197–1203
38. Fine JB, DiGirolamo M (1997) A simple method to predict cellular density in adipocyte metabolic incubations. Int J Obes Relat Metab Disord 21:764–768
39. Fuhrmann A, Lopes P, Sereno J, Pedro J, Espinoza DO, Pereira MJ, Reis F, Eriksson JW, Carvalho E (2014) Molecular mechanisms underlying the effects of cyclosporin A and sirolimus on glucose and lipid metabolism in liver, skeletal muscle and adipose tissue in an in vivo rat model. Biochem Pharmacol 88:216–228
40. Resjo S, Oknianska A, Zolnierowicz S, Manganiello V, Degerman E (1999) Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A. Biochem J 341(Pt 3):839–845
41. Pereira MJ, Palming J, Rizell M, Aureliano M, Carvalho E, Svensson MK, Eriksson JW (2012) mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes. Mol Cell Endocrinol 355:96–105
42. Rondinone CM, Smith U (1996) Okadaic acid exerts a full insulin-like effect on glucose transport and glucose transporter 4 translocation in human adipocytes. Evidence for a phosphatidylinositol 3-kinase-independent pathway. J Biol Chem 271:18148–18153
43. Fingar DC, Hausdorff SF, Blenis J, Birnbaum MJ (1993) Dissociation of pp70 ribosomal protein S6 kinase from insulin-stimulated glucose transport in 3T3-L1 adipocytes. J Biol Chem 268:3005–3008
44. Mizuki Y, Takaki M, Okahisa Y, Sakamoto S, Kodama M, Ujike H, Uchitomi Y (2014) Human Rho guanine nucleotide exchange factor 11 gene is associated with schizophrenia in a Japanese population. Hum Psychopharmacol 29:552–558
45. Fu M, Sabra MM, Damcott C, Pollin TI, Ma L, Ott S, Shelton JC, Shi X, Reinhart L, O’Connell J, Mitchell BD, Baier LJ, Shuldiner AR (2007) Evidence that Rho guanine nucleotide exchange factor 11 (ARHGEF11) on 1q21 is a type 2 diabetes susceptibility gene in the Old Order Amish. Diabetes 56:1363–1368
46. Liu J, Chen X, Guo Q, Ma X, Zhang J, Huang X, Zhang X, Zhang S (2011) Association of ARHGEF11 R1467H polymorphism with risk for type 2 diabetes mellitus and insulin resistance in Chinese population. Mol Biol Rep 38:2499–2505
47. Ma L, Hanson RL, Que LN, Cali AM, Fu M, Mack JL, Infante AM, Kobes S, Bogardus C, Shuldiner AR, Baier LJ (2007) Variants in ARHGEF11, a candidate gene for the linkage to type 2 diabetes on chromosome 1q, are nominally associated with insulin resistance and type 2 diabetes in Pima Indians. Diabetes 56:1454–1459
48. Banerjee J, Wedegaertner PB (2004) Identification of a novel sequence in PDZ-RhoGEF that mediates interaction with the actin cytoskeleton. Mol Biol Cell 15:1760–1775
49. Fukuhara S, Murga C, Zohar M, Igishi T, Gutkind JS (1999) A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to Rho. J Biol Chem 274:5868–5879
50. Kowluru A, Veluthakal R (2005) Rho guanosine diphosphate-dissociation inhibitor plays a negative modulatory role in glucose-stimulated insulin secretion. Diabetes 54:3523–3529
51. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS (2002) A central role for JNK in obesity and insulin resistance. Nature 420:333–336
52. Houssa B, de Widt J, Kranenburg O, Moolenaar WH, van Blitterswijk WJ (1999) Diacylglycerol kinase theta binds to and is negatively regulated by active RhoA. J Biol Chem 274:6820–6822